Kappa Opioid Receptor Agonist and Brain Ischemia
Chen Chunhua1, Xi Chunhua1, Sugita Megumi1
1Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania.
Abstract:
Opioid receptors, especially Kappa opioid receptor (KOR) play an important role in the pathophysiological process of cerebral ischemia reperfusion injury. Previously accepted KOR agonists activity has included anti-nociception, cardiovascular, anti-pruritic, diuretic, and antitussive effects, while compelling evidence from various ischemic animal models indicate that KOR agonist have neuroprotective effects through various mechanisms. In this review, we aimed to demonstrate the property of KOR agonist and its role in global and focal cerebral ischemia. Based on current preclinical research, the KOR agonists may be useful as a neuroprotective agent. The recent discovery of salvinorin A, highly selective non-opioid KOR agonist, offers a new tool to study the role of KOR in brain HI injury and the protective effects of KOR agonist. The unique pharmacological profile of salvinorin A along with the long history of human usage provides its high candidacy as a potential alternative medication for brain HI injury.
Insights
Kappa opioid receptor (KOR) agonists show neuroprotective effects in cerebral ischemia reperfusion injury. Salvinorin A, a selective KOR agonist, presents potential as a novel treatment for brain injury.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Kappa opioid receptor (KOR) is implicated in cerebral ischemia reperfusion injury.
- KOR agonists traditionally exhibit anti-nociceptive and other effects, but emerging evidence highlights neuroprotection.
Purpose of the Study:
- To review the properties of KOR agonists.
- To elucidate the role of KOR agonists in global and focal cerebral ischemia.
- To assess the neuroprotective potential of KOR agonists.
Main Methods:
- Review of preclinical research on KOR agonists and cerebral ischemia.
- Analysis of the role of salvinorin A as a selective KOR agonist.
Main Results:
- Preclinical data suggest KOR agonists possess neuroprotective properties.
- Salvinorin A, a selective KOR agonist, serves as a valuable tool for studying KOR's role in brain injury.
Conclusions:
- KOR agonists demonstrate potential as neuroprotective agents for cerebral ischemia.
- Salvinorin A's unique profile and human usage history suggest its candidacy for treating brain injury.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Opioid Analgesics: Morphine and Other Natural Cogeners


